Skip to search formSkip to main contentSkip to account menu

SUMO3 gene

Known as: SUMO3, SMALL UBIQUITIN-LIKE MODIFIER 3, SMT3A 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2019
Highly Cited
2019
Tumor cure with conventional fractionated radiotherapy is 65%, dependent on tumor cell–autonomous gradual buildup of DNA double… 
2018
2018
RORγt controls the differentiation of TH17 cells, which are mediators of autoimmune conditions such as experimental autoimmune… 
Highly Cited
2015
Highly Cited
2015
α-Synuclein, the major aggregating protein in Parkinson's disease, can be modified by the small protein SUMO, indicating a… 
Highly Cited
2014
Highly Cited
2014
Background and Purpose— Small ubiquitin-like modifier (SUMO) conjugation is a post-translational modification associated with… 
Highly Cited
2008
Highly Cited
2008
Small ubiquitin-like modifier (SUMO) proteases regulate the abundance and lifetime of SUMO-conjugated substrates by antagonizing… 
Highly Cited
2007
Highly Cited
2007
The sequential processing of the APP (amyloid precursor protein) by the beta- and gamma-secretase and generation of the Abeta… 
Highly Cited
2000
Highly Cited
2000
A novel Smt3-specific isopeptidase, SMT3IP1, was cloned using a yeast two-hybrid screen with Smt3b as bait. The clone, named… 
1998
1998
Mouse SMT3A and SMT3B cDNAs encoding ubiquitin‐like proteins of 110 and 95 amino acids, respectively, were isolated and sequenced…